FDA Drug Application (016891) for TALWIN COMPOUND by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number016891
Product Number001
FormTABLET;ORAL
Dosage325MG;EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTALWIN COMPOUND
Active IngredientASPIRIN; PENTAZOCINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient ASPIRIN60
List of drugs with Active Ingredient PENTAZOCINE HYDROCHLORIDE6


Back to FDA Applications sponsored by SANOFI AVENTIS US